7Baggers

Enveric Biosciences Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20160331 20160630 20160930 20161231 20170331 20170630 20170930 20171231 20180331 20180630 20180930 20181231 20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 -47.09-38.58-30.06-21.54-13.02-4.514.0112.53Milllion

Enveric Biosciences Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 2001-12-31 2001-09-30 2001-06-30 2001-03-31 2000-12-31 2000-09-30 2000-06-30 2000-03-31 1998-12-31 1998-09-30 1998-06-30 1998-03-31 1997-12-31 1997-09-30 1997-06-30 1997-03-31 1996-12-31 1996-09-30 1996-06-30 1996-03-31 1995-12-31 1995-09-30 1995-06-30 1995-03-31 1994-11-30 1994-05-31 1994-02-28 1993-11-30 
  revenue-26,340,499 8,483,030 8,254,941 9,602,528 9,064,565 9,148,857 11,015,057 10,686,196 10,283,176 10,576,254 11,075,840 11,063,010 11,454,598 12,529,928 12,268,259 12,340,927 12,387,129 10,058,558 6,686,938 7,012,964 4,463,125 3,930,938 -749,513 30,107 360,914 359,684 72,101 67,744 92,868 100,488 160,670 270,914 428,912 331,950 495,060 205,324 234,860 170,679 344,667 341,339 250,902 332,378 463,971 480,851 470,631 440,481 389,143 302,665 485,893 426,081 535,983 630,129 530,050 505,650 79,715 400,000 700,000 500,000 881,233 800,000 600,000 500,000 624,187 500,000 500,000 400,000 400,000 300,000 300,000 300,000 100,000 100,000 100,000 100,000 
  cost of revenue20,753,306 6,595,533 6,436,811 7,720,962 7,335,435 7,249,406 8,632,882 8,546,232 8,377,354 8,230,456 8,686,841 8,720,125 9,414,432 9,966,490 9,935,468 9,039,577 10,320,127 8,361,960 5,169,538 3,865,561 3,023,208 2,948,275 63,163 464 31,312 31,493 -25,354 6,774 9,288 10,189 16,548 12,752 42,890 33,872 50,143 26,114 18,133 17,004 28,831 35,147 22,497 35,942 24,618 37,977 39,719 28,202 15,693 12,500 41,090 5,630 58,259 48,152 44,289 11,548 34,190 100,000 100,000 100,000 100,000 85,540 100,000 
  gross profit-47,093,805 1,887,497 1,818,130 1,881,566 1,729,130 1,899,451 2,382,175 2,139,964 1,905,822 2,345,798 2,388,999 2,342,885 2,040,166 2,563,438 2,332,791 3,301,350 2,067,002 1,696,598 1,517,400 3,147,403 1,439,917 982,663 -812,676 29,643 329,602 328,191 97,455 60,970 83,580 90,299 144,122 258,162 386,022 298,078 444,917 179,210 216,727 153,675 315,836 306,192 228,405 296,436 439,353 442,874 430,912 412,279 373,450 290,165 444,803 420,451 477,724 581,977 485,761 494,102 45,525 300,000 700,000 400,000 881,233 700,000 500,000 500,000 538,647 500,000 400,000 400,000 400,000 300,000 300,000 300,000 100,000 100,000 100,000 100,000 
  operating expenses                                                                          
  research and development174,083 -1 12,839 144,901 109,421 62,068 83,358 99,290 97,374 93,842 106,223 95,482 125,651 122,145 102,141 109,003 92,254 97,532 119,437 123,603 105,542 172,978 223,381 137,322 151,931 186,294 88,850 113,194 -1,044,101 600,000 600,000 600,000 1,507,995 800,000 800,000 600,000 
  sales, general and administrative                                                                          
  total operating expenses-3,877,662 3,006,252 3,004,586 3,484,141 3,714,226 3,464,451 3,858,611 3,438,326 3,372,539 3,292,397 3,333,870 3,699,678 5,835,638 6,503,189 5,665,929 3,722,555 4,282,863 1,972,727 2,214,224 3,753,314 1,506,771 497,767 64,489 88,868 182,735 97,157 155,521 122,210 143,605 264,509 333,745 223,963 329,282 289,744 275,532 260,594 334,366 275,813 416,357 408,926 437,829 367,544 462,259 431,750 428,133 389,276 405,619 469,210 546,019 423,792 525,677 480,005 369,902 305,846 -1,210,257 1,600,000 1,800,000 1,500,000 2,437,908 1,600,000 1,600,000 1,600,000 22,242,394 1,600,000 2,200,000 1,200,000 -4,600,000 
  operating income-1,709,531 -1,118,755 -1,186,456 -1,602,575 -1,985,096 -1,565,000 -1,476,436 -1,298,362 -10,800,555 6,100,378 -944,871 -1,366,793 -3,886,421 -3,945,445 -3,508,274 -630,549 -2,170,219 -1,291,687 -936,639 -981,316 -66,800 484,924 -64,489 -59,225 146,867 231,034 -58,066 -61,240 -60,025 -174,210 -189,623 34,199 56,740 8,334 169,385 -81,384 -117,639 -122,138 -100,521 -102,734 -209,424 -71,108 -22,906 11,124 2,779 23,003 -32,169 -179,045 -101,216 -25,211 -47,953 101,972 115,859 188,256 1,255,782 -1,300,000 -1,100,000 -900,000 -1,786,411 -700,000 -1,100,000 -900,000 -21,703,747 -1,100,000 -1,800,000 -800,000 -4,200,000 300,000 300,000 300,000 100,000 100,000 100,000 100,000 
  net income-2,545,557 -961,174 -1,573,418 -1,784,527 -2,528,735 41,299 -1,256,568 -1,859,972 -19,765,009 5,699,467 -1,260,221 -1,571,753 -1,005,840 -4,067,604 -3,279,381 -721,988 -2,446,526 -1,718,549 -1,209,803 -1,160,271 -249,364 110,969 -48,492 472,342 149,768 233,657 -55,172 -61,798 -62,989 -173,391 -185,640 36,545 57,566 10,014 170,141 -80,576 -123,259 -123,796 -102,041 -106,502 -212,461 -74,449 -17,156 11,124 3,046 21,280 27,188 -175,320 -97,509 5,535 -4,370 103,814 112,044 170,531 -2,692,061 -1,100,000 -1,100,000 -900,000 -1,819,821 -700,000 -1,200,000 -1,000,000 -21,795,170 -1,100,000 -1,800,000 -800,000 -1,100,000 -800,000 -600,000 -600,000 -600,000 -400,000 -400,000 -400,000 

We provide you with 20 years income statements for Enveric Biosciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Enveric Biosciences stock. Explore the full financial landscape of Enveric Biosciences stock with our expertly curated income statements.

The information provided in this report about Enveric Biosciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.